跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ikshamox - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ikshamox
Approved
STANDARD
Ikshamox
Makcur Laboratories Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1271dc37f4ea9ebf
Company
Makcur Laboratories Limited
Type
Standard
Approval Details
Approval Id
1271dc37f4ea9ebf
Drug Approval Philippines Name
Ikshamox
Product Name
Ikshamox
Registration Number
DRP-13578-02
Brand Name
Ikshamox
Generic Name
Moxifloxacin (as hydrochloride)
Dosage Form
Ophthalmic Solution
Dosage Strength
5 mg/mL (0.5% w/v)
Manufacturer
Makcur Laboratories Limited
Importer
Afree Pharmaceutical Distribution Corp.
Distributor
Bliss Pharma Distribution and Consultancy Corp.
Issuance Date
24 April 2024
Expiry Date
13 March 2028
Pharmacologic Category
Antiinfective (Fluoroquinolone)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1271dc37f4ea9ebf
Type
Standard
Back to Philippines FDA Approvals